Profile
International Journal of Gynecology & Clinical Practices Volume 4 (2017), Article ID 4:IJGCP-128, 4 pages
http://dx.doi.org/10.15344/2394-4986/2017/128
Research Article
Special Issue: Gynecology & Surgical Oncology
Is Tumor Size a Predictor of Survival in Stage IIA Cervical Cancer? A Comparison Between the Old and the New FIGO Staging Criteria

Yong Kuei Lim1*, Hui Xian Chin1, Xiao Hui Lin1, Kwai Lam Yam1, Yin Nin Chia1, Hoon Seng Khoo Tan2, Ming Chert Richard Yeo2, Swee Peng Yap2, Lay Tin Soh2 and Eu Jin Chua2

1Department of Gynecological Oncology, KK Women’s and Children’s Hospital, 100 Bukit Timah Road, 229899, Singapore
2Division of Radiation Oncology, National Cancer Centre, 11 Hospital Drive, 169610, Singapore
Dr. Yong Kuei Lim, Department of Gynecological Oncology, KK Women’s and Children’s Hospital, 100 Bukit Timah Road, 229899, Singapore; E-mail: timothy.lim.y.k@singhealth.com.sg
07 January 2017; 28 March 2017; 31 March 2017
Lim YK, Chin HX, Lin XH, Yam KL, Chia YN, et al. (2017) Is Tumor Size a Predictor of Survival in Stage IIA Cervical Cancer? A Comparison Between the Old and the New FIGO Staging Criteria. Int J Gynecol Clin Pract 4: 128. doi: http://dx.doi.org/10.15344/2394-4986/2017/128

References

  1. National Registry of Diseases Office Singapore Cancer Registry Annual Registry Report: Trends in Cancer Incidence in Singapore 2009 – 2013 [View]
  2. Pecorelli S, Zigliani L, Odicino F (2009) Revised FIGO staging for carcinoma of the cervix. Int J Gynaecol Obstet 105: 107-108 [CrossRef] [Google Scholar] [PubMed]
  3. Peters WA, Liu PY, Barrett RJ , Stock RJ, Monk BJ, Berek JS, et al. (2000) Concurrent chemotherapy and pelvic radiation therapy alone as adjuvant therapy after radical surgery in high risk early stage cancer of the cervix. J Clin Oncol 18 : 1606-1613 [CrossRef] [Google Scholar] [PubMed]
  4. Delgado G, Bundy B, Zaino R, Sevin BU, Creasman WT, et al. (1990) Prospective surgical-pathological study of disease free-interval in patients with stage Ib squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol 38: 352-379 [CrossRef] [Google Scholar] [PubMed]
  5. Yeo RM, Chia YN, Namuduri RP, Yap SP, Soong YL, et al.(2011) Tailoring adjuvant radiotherapy for stage IB-IIA node negative cervical carcinoma after radical hysterectomy and pelvic lymph node dissection using the GOG score. Gynecol Oncol 123: 225-229 [CrossRef] [Google Scholar] [PubMed]
  6. Horn LC, Fischer U, Raptis G, Bilek K, Hentschel B, et al. (2007) Tumor size is of prognostic value in surgically treated FIGO stage II cervical cancer. Gynecol Oncol 107: 310-315 [CrossRef] [Google Scholar] [PubMed]
  7. Garg G, Shah JP, Toy EP, Christensen C, Deppe G, et al. (2011) Stage IIA1 versus stage IIA2 cervical cancer: does the new staging criteria predict survival? Int J Gynecol Cancer 21: 711-716 [CrossRef] [Google Scholar] [PubMed]
  8. Lai JC, Chou YJ, Huang N, Tsai JJ, Huang SM, et al. (2013) Survival analysis of Stage IIA1 and IIA2 cervical cancer patients. Taiwan J Obstet Gynecol 52: 33-38 [CrossRef] [Google Scholar] [PubMed]
  9. Hongladaromp W, Tantipalakorn C, Charoenkwan K, et al. (2014) Locoregional spread and survival of stage IIA1 versus stage IIA2 cervical cancer. Asian Pac J Cancer Prev 15: 887-890 [CrossRef] [Google Scholar] [PubMed]
  10. Wagner AE, Pappas L, Ghia AJ, Gaffney DK (2013) Impact of tumor size on survival in cancer of the cervix and validation of stage IIA1 and IIA2 subdivisions. Gynecol Oncol 129 :517-521 [CrossRef] [Google Scholar] [PubMed]
  11. Landoni F, Maneo A, Colombo A, Placa F, Milani R, et al. (1997) Randomised study of radical surgery versus radiotherapy for stage Ib–IIa cervical cancer. Lancet 350: 535-540 [CrossRef] [Google Scholar] [PubMed]